Free Trial
OTCMKTS:IMUN

Immune Therapeutics (IMUN) Stock Price, News & Analysis

Immune Therapeutics logo
$0.09 0.00 (0.00%)
As of 10/19/2023

About Immune Therapeutics Stock (OTCMKTS:IMUN)

Key Stats

Today's Range
$0.09
$0.09
50-Day Range
$0.09
$0.09
52-Week Range
$0.07
$1.30
Volume
12 shs
Average Volume
15,246 shs
Market Capitalization
$7.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMUN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immune Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

IMUN Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
How Vaccines Train the Immune System
See More Headlines

IMUN Stock Analysis - Frequently Asked Questions

Immune Therapeutics' stock was trading at $0.0930 at the beginning of the year. Since then, IMUN stock has increased by 0.0% and is now trading at $0.0930.

Shares of IMUN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Immune Therapeutics investors own include Asia Broadband (AABB), CRISPR Therapeutics (CRSP), Edge Therapeutics (EDGE), Gilead Sciences (GILD), Northwest Biotherapeutics (NWBO), Galiano Gold (AKG) and Agritek (AGTK).

Company Calendar

Today
8/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:IMUN
CIK
1559356
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.54 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-544.75%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
-3.10

Miscellaneous

Outstanding Shares
83,660,000
Free Float
41,335,000
Market Cap
$7.78 million
Optionable
Not Optionable
Beta
0.46

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:IMUN) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners